Trials / Terminated
TerminatedNCT02311764
Carboplatin in Castration-resistant Prostate Cancer
Single Arm Open Label Phase II Pilot Study of Carboplatin in Patients With Metastatic Castrationresistant Prostate Cancer (CRPC) and PTEN Loss and/or DNA Repair Defects
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Aurelius Omlin · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Open label, non-randomised phase II clinical pilot study
Detailed description
Pilot Study of weekly Carboplatin in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer (CRPC) and DNA repair defects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carboplatin | Carboplatin will be administered weekly |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2014-12-08
- Last updated
- 2020-01-23
Locations
3 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02311764. Inclusion in this directory is not an endorsement.